Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
A view of the Sun Pharmaceutical Industries Limited | Photo Credit: The Hindu Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an all‑cash transaction with an enterprise valuation of $11.75 billion. Organon is a…
Read More “Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal” »